Pelthos Therapeutics Inc. (PTHS) stock
PTHSNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.84−0.31 (-4.34%)
Close on Nov 17, 2026Market cap $26.19MP/E –Yield –
Pelthos Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pelthos Therapeutics's enterprise value was $10.73M on Nov 11, 2026, against $73.57M a year earlier. Over the last 3 years it ranged from $1.21M to $81.61M, with a median of $12.36M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $10.73M | -86.9% |
| 2025 | Dec 31, 2025 | $81.61M | +3198.1% |
| 2024 | Dec 31, 2024 | $2.47M | – |
See a number that looks wrong?